Asian Hospital and Medical Center in the Philippines has unveiled its 'Fantastic 6 sa 26' strategic plan, outlining key initiatives to advance hospital operations and elevate B2B healthcare standards across Asia.

Novartis plans to build a 46,000-square-foot radioligand therapy manufacturing site in Denton Texas operational by 2028 serving Southern US patients and expanding its US network.

University of Florida Health is restructuring operations by transferring 299 nutrition and food service positions to an external vendor across its four hospitals to optimize efficiency.

Merck announces a new organizational structure for its Human Health unit, creating dedicated Oncology and Specialty, Pharma & Infectious Diseases Business Units to drive commercial success in hospital pharmaceutical portfolios.

Columbia Asia Hospital Tebrau in Johor Bahru introduces robotic-assisted knee replacement surgery to enhance precision and patient outcomes, alongside plans for NCD focus and facility expansion.

Laos Ministry of Health is transforming public hospitals into self-governing entities to improve service standards, resource allocation, and attract more patients.

The European Medicines Agency has updated information on critical pharmaceuticals Wezenla ustekinumab and Cejemly sugemalimab, impacting hospital procurement and patient care across Europe.

Merck partners with Mayo Clinic to leverage AI, advanced analytics, and multimodal clinical data for accelerating drug discovery and precision medicine initiatives.

US medical device firm Edwards Lifesciences has voluntarily terminated its controversial anti-copycat policy, thereby escaping a formal European Commission investigation impacting hospital procurement of cardiovascular devices.

Hospitals' mandated price postings under Trump policies are primarily utilized by insurers for contract negotiations rather than patient shopping, amid ongoing compliance issues and regulatory enhancements.